<DOC>
	<DOCNO>NCT01538550</DOCNO>
	<brief_summary>The Norwegian government fund pilot study national colorectal cancer screen programme . This imply initiation screen pilot catchment area two hospital Norway . The target population average risk men woman age 50-74 year . The programme design comparative effectiveness programme evaluate acceptance test performance two screen method - fecal occult blood testing ( FOBT ) flexible sigmoidoscopy ( FS ) . This protocol describe main methodological issue , necessary resource expect effect .</brief_summary>
	<brief_title>Pilot Study National Screening Programme Bowel Cancer Norway</brief_title>
	<detailed_description>There several candidate screen modality - fecal occult blood ( FOBT ) , flexible sigmoidoscopy , colonoscopy , CT MRI colonography range molecular marker . Of , FOBT FS subject long-term follow-up randomise trial ( RCTs ) . These two modality test head-to-head comparison 1:1 randomisation . Previous study suggest attendance FS may lower FOBT . However , participation show decline repetitive round require FOBT , infrequent once-only screening may suffice FS . A good test performance FS make uncertain method may beneficial public health perspective . This first time national screening programme design platform comparative effectiveness study . The pilot study carry two hospital catchment area South-East Norway - target population 70,000 men woman 50-74 year age - altogether 140,000 individual randomise 1:1 screen immunochemical test faecal occult blood ( iFOBT ) biennially FS . The primary endpoint colorectal mortality reduction 10 year . Attendance FS expect 50 % 60 % iFOBT . Expected CRC mortality reduction 30 % ( 286 CRC death ) FS arm 15 % ( 143 CRC death ) iFOBT arm ( intention-to-treat ) . In 1:1 randomisation 80 % statistical power significance level 5 % require 65,000 individual arm disclose statistically significant difference FS iFOBT screen intention-to-treat model . We expect 5 % iFOBTs group test positive require colonoscopy work-up . A positive FS define 'any advanced neoplasia ' ( CRC , adenoma &gt; 10mm , adenoma high-grade dysplasia villous component ) . A finding advanced neoplasia expect 5 % FS require full colonoscopy . Study entry-date : First round screen iFOBT arm ( 70,000 invitee ) finish year 1 2 trial flexible sigmoidoscopy arm ( 70,000 invitee ) require year 1-4 complete . Randomization altogether 140,000 invitee perform year 1 trial - thus render flexible sigmoidoscopy arm prone relevant time-dependent event randomization time screen actually offer . Therefore , primary entry-date define day real ( attend ) suggest appointment ( non-attenders ) screen arm letter invitation state suggest day appointment choose randomization . Primary entry date iFOBT arm similarly define date iFOBT sample attend date mail iFOBT-kits plus one week non-compliant invitee . Randomization date choose secondary study entry date allow comparative analysis effect choose two entry date definition .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<criteria>men woman age 5074 year live define geographic area SouthEast Norway ( catchment area two hospital ) previous colorectal cancer</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>cancer</keyword>
	<keyword>colon</keyword>
	<keyword>rectum</keyword>
	<keyword>adenoma</keyword>
	<keyword>screen</keyword>
	<keyword>iFOBT</keyword>
	<keyword>flexible sigmoidoscopy</keyword>
	<keyword>randomize trial</keyword>
</DOC>